Ainos, Inc. reported financial results for the first quarter ended March 31, 2026.
“On May 13, 2026, Ainos, Inc. (the “Company”) reported its financial results for the quarter ended March 31, 2026.”
Ainos, Inc. — fact timeline
Source-grounded facts extracted from Ainos, Inc.'s SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
Ainos, Inc. reported financial results for year ended December 31, 2025.
“On March 30, 2026, Ainos, Inc. (the “Company”) announced its financial results for the year ended December 31, 2025.”
Ainos, Inc. issued 1,160,000 shares of common stock of common stock to ScentAI Inc. for in exchange for 116,000,000 shares of common stock to be issued by ScentAI.
“On December 30, 2025, following the approval by the board of directors of Ainos, Inc. (the “Company”), the Company issued 1,160,000 shares of common stock (“AIMD Shares”), par value $0.01 (the “Common Stock”) to its wholly owned subsidiary, ScentAI Inc. (“ScentAI”), in exchange for 116,000,000 shares of common stock to be issued by ScentAI.”
Ainos, Inc. engaged YCM CPA Inc. as its auditor.
“On July 31, 2025, the audit committee of the board of directors of the Company (the “Audit Committee”) engaged YCM CPA Inc. (“YCM”) as the Company’s new independent registered public accounting firm”
KCCW Accountancy Corp. resigned as auditor of Ainos, Inc..
“On July 30, 2025, KCCW Accountancy Corp. (“KCCW”) resigned as independent registered public accounting firm of Ainos, Inc.”
Ainos, Inc.: Amended Restated Certificate of Formation to effect a 1-for-5 reverse stock split of common stock (effective 2025-06-30).
“Effective June 30, 2025, at 5:01 a.m., Central time (the “Effective Time”), Ainos, Inc. (the “Company”) filed a certificate of amendment (the “Certificate of Amendment”) to amend its Restated Certificate of Formation, as amended, with the Secretary of the State of Texas, to effect a reverse stock split of the Company’s common stock, par value $0.01 (the “Common Stock”) at a ratio of 1-for-5 (the “Reverse Stock Split”).”
Lawrence K. Lin changed role as Executive Vice President of Operations at Ainos, Inc..
“As of August 9, 2024, Lawrence K. Lin transitioned from his role as the Company’s Executive Vice President of Operations, effective August 9, 2024.”
Ainos, Inc. reported first quarter ended March 31, 2024 results: revenue US$20,729, net income US$3,314,810.
“Revenues were US$20,729 in the first quarter of 2024, compared to US$49,164 in the same period of 2023, reflecting the Company’s cessation of sales of its COVID-19 antigen rapid test kits during the first quarter of 2024 after a strategic pivot shift.”
Ainos, Inc. incurred convertible notes of $9,000,000 with ASE Test, Inc. at six percent compound interest maturing May 3, 2027.
“On May 3, 2024, Ainos, Inc., a Texas corporation (“Ainos”, “we” or the “Company”), entered into a Convertible Note and Warrant Purchase Agreement (the “Agreement”) with ASE Test, Inc., Taiwanese company (“ASE Test”), pursuant to which the Company issued to ASE Test a convertible note in the aggregate principal amount of US$9,000,000.”
Ainos, Inc. entered into Convertible Note and Warrant Purchase Agreement with ASE Test, Inc. valued at US$9,000,000 (effective 2024-05-03).
“On May 3, 2024, Ainos, Inc., a Texas corporation (“Ainos”, “we” or the “Company”), entered into a Convertible Note and Warrant Purchase Agreement (the “Agreement”) with ASE Test, Inc., Taiwanese company (“ASE Test”), pursuant to which the Company issued to ASE Test a convertible note in the aggregate principal amount of US$9,000,000.”
Christopher Hsin-Liang Lee was appointed as Chief Financial Officer at Ainos, Inc..
“On March 15, 2024, the Board of Directors appointed Christopher Hsin-Liang Lee as the Chief Financial Officer of Ainos, Inc. (the “Company”).”
Meng-Lin Sung resigned as Chief Financial Officer at Ainos, Inc..
“On March 13, 2024, Meng-Lin Sung, the Chief Financial Officer of Ainos, Inc. (the “Company”), resigned from her positions with the Company, effective as of such date.”
Ainos, Inc. reported the year ended December 31, 2023 results: revenue US$122,112, net income US$13,770,549.
“amount of US$3 million. These transactions provided us with additional capital as we implement our growth strategy.” Full Year 2023 Financial Results Revenues Revenues were US$122,112, compared to US$3,519,627 in the full year of 2022, reflecting a decrease in selling price and sales volume of the Company's COVID-19 Antigen Rapid Test Kits attributable to the”
Ainos, Inc. amended First Amendment to Senior Secured Convertible Promissory Note with Lind Global Fund II LP valued at USD 1,750,000.00.
“Ainos, Inc., a Texas Corporation (“Ainos”, “we” or the “Company”), exercised their rights under Section 2.1 of the SPA to raise additional financing in the principal amount of USD 1,750,000.00 with USD 875,000.00 funded at closing and USD 875,000.00 to be funded subject to an effective registration statement and other conditions specified in the SPA and the First Amendment to Senior Secured Convertible Promissory Note (as amended, the "Note")”
Ainos, Inc. amended Addendum Agreement with Taiwan Carbon Nano Technology Corporation valued at NT$5 million (approximately USD$161,000) (effective 2024-01-09).
“On January 9, 2024, the Company and TCNT entered into an addendum to the Product Development Agreement (“Addendum Agreement”) in connection with the scope of co-development and certain terms.”
Ainos, Inc.: Amended Certificate of Formation to effect a 1-for-5 reverse stock split and increase authorized preferred shares from 10,000,000 to 50,000,000 (effective 2023-12-14).
“Reverse Stock Split Effective December 14, 2023 at 9:00 a.m., Eastern time (the “Effective Time”), Ainos, Inc. (the “Company”) amended its Certificate of Formation (the “Amendment”) to effect a reverse stock split of the Company’s common stock, par value $.01 (the “Common Stock”) at a ratio of 1-for-5 (the “Reverse Stock Split”).”
Ainos, Inc. shareholders approved To approve, by non-binding vote, the Advisory Approval of Executive Compensation of the named executive officers. at the 2023-12-08 meeting.
“Proposal 2: To approve, by non-binding vote, the Advisory Approval of Executive Compensation Fiscal 2022 compensation paid to the Company's named executive officers, as disclosed in the Company's proxy statement ("Say-on-Pay").”
Ainos, Inc. shareholders approved To ratify the appointment of KCCW Accountancy Corp. as the independent registered public accounting firm for the fiscal year ended December 31, 2023. at the 2023-12-08 meeting.
“Proposal 1: To ratify the appointment of KCCW Accountancy Corp. as the Company's independent registered public accounting firm for the Company's fiscal year ended December 31, 2023.”
Ainos, Inc. reported third quarter ended September 30, 2023 results: revenue US$24,489, net income US$2,975,846.
“Revenues were US$24,489 in the third quarter of 2023, compared to US$1,757,774 in the same period of 2022”
Ainos, Inc. entered into Securities Purchase Agreement with Lind Global Fund II LP valued at up to $10 million (effective 2023-09-25).
“On September 25, 2023, AINOS, INC. (the “Company”) entered into a securities purchase agreement (the “Securities Purchase Agreement”) with Lind Global Fund II LP (“Lind”). The Securities Purchase Agreement provides for loans in an aggregate principal amount of up to $10 million under various tranches (the “Financing”).”
Ainos, Inc. amended loan of $300,000 in principal with Ainos, Inc., a Cayman Islands company at 1.85% per annum maturing March 31, 2025.
“On August 17, 2023, Ainos, Inc., a Texas corporation (the “Company”), executed a Promissory Note Extension Agreement (the “KY Agreement”) to extend the maturity date of that certain Non-Convertible Promissory Note in favor of Ainos, Inc., a Cayman Islands company, dated March 17, 2022 in the Principal Amount of $800,000 and 1.85% per annum interest on unpaid principal and accrued interest (the “KY Note”). Pursuant to the KY Agreement, the unpaid amounts due under the Note are $300,000 in principal along with accrued interest and the maturity date is extended to March 31, 2025.”
Ainos, Inc. amended Promissory Note Extension Agreement with Ainos, Inc., a Cayman Islands company valued at $300,000 (effective 2023-08-17).
“On August 17, 2023, Ainos, Inc., a Texas corporation (the “Company”), executed a Promissory Note Extension Agreement (the “KY Agreement”) to extend the maturity date of that certain Non-Convertible Promissory Note in favor of Ainos, Inc., a Cayman Islands company, dated March 17, 2022 in the Principal Amount of $800,000 and 1.85% per annum interest on unpaid principal and accrued interest (the “KY Note”).”
Ainos, Inc. reported second quarter ended June 30, 2023 results: revenue US$28,555, net income US$2,349,727.
“us to advance the device towards commercialization.” Meng-Lin Sung, Chief Financial Officer of Ainos, commented, “During the second quarter of 2023, we generated revenues of US$28,555 as we recalibrated our business to adapt to the post-COVID era. As we continued to invest in long-term growth and product development initiatives, we diligently managed our”
Ainos, Inc. entered into Co-Development Agreement with Nisshinbo Micro Devices Inc. and Taiwan Inabata Sangyo Co., Ltd. (effective 2023-08-09).
“On August 9, 2023, Ainos, Inc., a Texas corporation (the “Company”), entered into Co-Development Agreement (the “Agreement”) with Nisshinbo Micro Devices Inc., a Japan corporation (“NISD”), and Taiwan Inabata Sangyo Co., Ltd., a Taiwan corporation (“Inabata”).”
Ainos, Inc. received a nasdaq extension granted notice regarding minimum bid price (rules 5810(c)(3)(A)).
“July 6, 2023, Ainos, Inc. (the “Company”) received notice from the Nasdaq Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) advising that Staff has determined that the Company is eligible for an additional 180 calendar day period, or until January 2, 2024, to regain compliance with its minimum bid price requirement pursuant to the Nasdaq Listing Rule 5810(c)(3)(A). The notification has no immediate effect on the listing of the Company's common stock on Nasdaq. The Company has a period of an additional 180 calendar days from the date of notification, whi”
Meng-Lin Sung (Amanda) was appointed as Chief Financial Officer at Ainos, Inc..
“On May 17, 2023, the Board of Directors appointed Meng-Lin Sung (Amanda) as the Chief Financial Officer of the Company.”
Hui-Lan (Celia) Wu retired as Chief Financial Officer at Ainos, Inc..
“On May 16, 2023, Ms. Hui-Lan (Celia) Wu retired as the CFO of the Company.”
Ainos, Inc. engaged KCCW Accountancy Corp. as its auditor.
“(a) The Audit Committee (the “Committee”) of the Board of Directors of Ainos, Inc., a Texas corporation (the “Company”) recently conducted a competitive selection process to determine the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023. The Committee invited several PCAOB registered public accounting firms to participate in this process. As a result of this process, the Committee decided not to renew or extend the Company’s engagement of PWR CPA LLP (“PWR”), as the Company’s independent registered public accounting firm. PWR’s audit reports on the Company’s consolidated financial statements as of and for the fiscal years ended December 31, 2021 and 2022 did not contain an adverse opinion or a disclaimer of opinion and were not qualified or modified as to uncertainty, audit scope or accounting principles. During the fiscal years ended D”
Ainos, Inc. incurred convertible notes of $1,000,000 with Li-Kuo Lee at six percent (6%) compounded maturing two (2) years from the effective date.
“Amount (the “Convertible Note”). The Purchaser’s obligation to pay the total aggregate Principal Amount in three (3) tranches in the amounts of One Million Dollars (USD $1,000,000) (the “First Tranche”), Five Hundred Thousand Dollars (USD $500,000) (the “Second Tranche”), and Five Hundred Thousand Dollars (USD $500,000) (the “Third Tranche”) is”
Ainos, Inc. incurred convertible notes of $2,000,000 with ASE Test, Inc. at six percent (6%) compounded maturing two (2) years from the effective date.
“a shareholder of the Company’s controlling shareholder, Ainos, Inc., a Cayman Islands corporation. Pursuant to the Agreement, the Purchaser will pay a total aggregate amount of $2,000,000 U.S.D. (the “Principal Amount”) to the Company in exchange for one or more Convertible Promissory Note(s) issued by the Company in the total aggregate Principal Amount (the”
Ainos, Inc. entered into Agreement with Li-Kuo Lee valued at $1,000,000 U.S.D. (effective 2023-03-13).
“Reference is made to that certain Convertible Note Purchase Agreement dated as of March 13, 2023 (the "Agreement") by and between Ainos, Inc., a Texas corporation (the "Company") and Li-Kuo Lee (the "Purchaser").”
Ainos, Inc. entered into Agreement with ASE Test, Inc. valued at $2,000,000 U.S.D. (effective 2023-03-13).
“Reference is made to that certain Convertible Note Purchase Agreement dated as of March 13, 2023 (the "Agreement") by and between Ainos, Inc., a Texas corporation (the "Company") and ASE Test, Inc. (the "Purchaser").”
Ainos, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).
“January 5, 2023, Ainos, Inc. (the “Company”) received a deficiency letter from the Nasdaq Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, for the last 30 consecutive business days, the closing bid price for the Company’s common stock has been below the minimum $1.00 per share required for continued listing on The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Requirement”). The Nasdaq deficiency letter has no immediate effect on the listing of the Company’s common stock, and its comm”
Pao-Sheng Wei was appointed as Director, Audit Committee Chairman at Ainos, Inc..
“On June 15, 2022, the Board appointed Pao-Sheng Wei to the Board, the Compensation Committee, and the Audit Committee and as Chairman of the Audit Committee and as an Audit Committee Financial Expert.”
Hsiu-Chen Chiu resigned as Director at Ainos, Inc..
“On June 15, 2022, the Board accepted the resignation of Hsiu-Chen Chiu from the Board, the Compensation Committee, the Audit Committee and as Audit Committee Chairperson.”
Pao-Sheng Wei was appointed as Director at Ainos, Inc..
“On June 15, 2022, the Board appointed Pao-Sheng Wei to the Board, the Compensation Committee and as Chairman of the Compensation Committee, and the Audit Committee and as Chairman of the Audit Committee and as an Audit Committee Financial Expert.”
Hsiu-Chen Chiu resigned as Director at Ainos, Inc..
“On June 15, 2022, the Board accepted the resignation of Hsiu-Chen Chiu from the Board, the Compensation Committee and as Chairperson of the Compensation Committee, and the Audit Committee and as Audit Committee Chairperson.”
Chih-Heng (Jack) Lu was appointed as Corporate Secretary at Ainos, Inc..
“Mr. Chih-Heng (Jack) Lu, age 41, was appointed as Corporate Secretary to serve the Board and Company's Taiwan Branch Office.”
John Junyong Lee was appointed as Chief Legal Counsel and Corporate Secretary at Ainos, Inc..
“Mr. John Junyong Lee, Esq. age 54, was re-appointed as Chief Legal Counsel and Corporate Secretary of the Company.”
Lawrence K. Lin was elected as Executive Vice President of Operations at Ainos, Inc..
“Mr. Lawrence K. Lin, age 51, was elected to serve as Executive Vice President of Operations of the Company.”
Hui-Lan (Celia) Wu was elected as Chief Financial Officer at Ainos, Inc..
“Ms. Hui-Lan (Celia) Wu, age 61, was elected to serve as the CFO of the Company.”
Chun-Hsien Tsai resigned as Chief Financial Officer at Ainos, Inc..
“Mr. Chun-Hsien Tsai resigned as Chief Financial Officer (CFO) and the vacancy was filled by the election of his successor, Ms. Hui-Lan (Celia) Wu.”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.